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Abstract: OBJECTIVE To examine if lower urinary tract symptom (LUTS) progression was related
to anthropometric and lifestyle factors. MATERIAL AND METHODS The analysis included 5495 men
who participated in the EPIC-Heidelberg cohort (recruited 1994-1998) and who reported an International
Prostate Symptom Score < 8 at follow-up 4 (FUP4, 2007-2009), had not reported taking ￿-adrenoreceptor
antagonists or 5-￿ reductase inhibitors or prostate surgery for benign prostatic hyperplasia/LUTS treat-
ment. LUTS progression was defined as an International Prostate Symptom Score ￿ 8 at FUP5 (2010-
2012). Using logistic regression analysis, education, marital status, satisfaction with life, satisfaction with
health, history of diabetes and of hypertension, smoking, alcohol consumption, body mass index (BMI),
waist circumference, and physical activity were examined as potential LUTS risk factors adjusting for
age. RESULTS Increase in BMI between baseline and FUP4 of ￿ 2 BMI units was related to LUTS
progression (odds ratio 1.30, 95% confidence interval 1.08-1.57) compared with stable BMI. Compared to
men who were very satisfied with life at baseline, those who were satisfied (1.28, 1.11-1.47), unsatisfied
(1.80, 1.31-2.46) or very unsatisfied with life (1.43, 0.62-3.34) were more likely to report LUTS progres-
sion. Men with longer education had higher odds of LUTS progression than men with primary education
only (1.25, 1.06-1.48). Adjusting for BMI or lifestyle factors did not attenuate these associations. Smok-
ing habits, alcohol consumption, physical activity, self-reported history of diabetes or hypertension, and
marital status were not related with LUTS progression. CONCLUSION Our results confirm some, but
not all previously observed risk factors for LUTS progression.
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Introduction 
Many men experience lower urinary tract symptoms (LUTS) as they age 1-3. So far, however, 
increasing age is the only factor that is clearly related with LUTS progression, and only few studies 
have examined which other factors are actually associated with LUTS progression or improvements. 
Factors most often examined so far are obesity and physical activity 4-9, but also chronic disease 
conditions, smoking, alcohol consumption or education 10-13. Results of these studies are rather 
heterogeneous. Obesity tends to be associated with disease progression in several, but not all 4,5,14 
studies, and physical activity tends to show the opposite effect, although again the observed 
associations are not fully consistent 4,6,8-12. 
Given the paucity of studies that addressed the question whether other factors than obesity are 
related to the risk of LUTS progression in elderly men, we used data of the EPIC-Heidelberg cohort. In 
this cohort, LUTS was assessed at two points during prospective follow-up, allowing for examining 
the effect of a variety of lifestyle factors on LUTS progression among middle-aged and elderly men. 
 
Material and Methods 
The EPIC study started in the early 1990s as a European initiative to examine risk factors for cancer 
and other chronic diseases. Participants were recruited in 10 European countries between 1994 and 
1998, including more than 25,000 men and women in Heidelberg 15,16. Men 40 to 65 years old and 
women aged 35 to 65 who lived in Heidelberg and surrounding municipalities were included in the 
cohort. At baseline, all participants filled in a lifestyle and a dietary questionnaire and provided more 
information during a standardized interview. Lifestyle questions included a detailed history of 
smoking and alcohol consumption, physical activity, medication use, and history of chronic diseases 
15,17. Body weight, height, waist and hip circumferences were measured by a trained interviewer. 
In EPIC-Heidelberg, follow-up (FUP) for chronic diseases is conducted every 2-3 years 18 via 
questionnaire. Benign prostatic hyperplasia has not been assessed as such at baseline or during FUP 
1-3, but all participants were asked to report medical diagnoses of benign tumors (including BPH) and 
any type of surgery, including transurethral resection of the prostate (TURP). Medication use has 
been assessed at baseline and all FUPs and has been coded using the ATC systematic. In our analysis, 
we considered the following drug groups: G04CA (α-adrenoreceptor antagonists), G04CB (5-α 
reductase inhibitors), and G04CX (other drugs used in BPH; this group includes plant-based and 
homeopathic products).  
Outcome assessment: In follow-up (FUP) rounds 4 (conducted 2007-2009) and 5 (2010-2012), male 
study participants were asked to complete the International Prostate Symptom Score (IPSS), which 
assesses the frequency of the lower urinary tract symptoms "incomplete emptying"," frequency", 
"intermittency", "urgency", "weak stream", "straining", and "nocturia". For the first six questions (1-
6) men can choose from the replies ‘not at all’, less than 1 in 5’, ‘less than half the time’, ‘more than 
half the time’, or ‘almost always’. Response choices for the last question (7) were ‘none’, ‘1 time’, ‘2 
times’, ‘3 times’, ‘4 times’, ‘5 times or more’. A score ranging from 0 to 5 was assigned for each of the 
seven symptoms. A total IPSS was calculated by summing the individual scores ranging from 0-35.  
In addition to the IPSS, men were asked whether a physician had (ever) diagnosed BPH (yes/no; if 
yes, the respective year), whether they took any BPH/LUTS medication (yes/no), including over-the-
counter drugs, and whether they have had BPH surgery (yes/no; if yes, the respective year). 
Study population: Of 11,928 male participants of the EPIC-Heidelberg cohort, men were eligible for 
our analysis if they had participated in FUP 4 and FUP 5, had not been diagnosed with prostate 
cancer until FUP 5, had replied to at least 4 of the 7 IPSS questions, had not reported taking α-
adrenoreceptor antagonists or 5-α reductase inhibitors for treatment of BPH or LUTS up to FUP 4, 
and had not reported prostate surgery for BPH/LUTS treatment up to FUP 4, leaving 6,917 men. In 
our analysis, we only included men with IPSS ≤ 7 at FUP 4 and classified them as having “no/mild 
LUTS”; thus, the analytical cohort comprised 5,495 men. 
Statistical analysis: LUTS progression was defined as progression from "no/mild LUTS" (IPSS ≤ 7) at 
FUP4 to "moderate/severe LUTS" (IPSS of 8 or higher) at FUP 5. Smoking was categorized into never, 
former and current smokers. Education was determined by highest degree of education and 
categorized into "no formal education / primary school completed", "technical/professional school 
completed", "secondary school", or "longer education (i.e., university degree)". Marital status was 
coded as "single", "married / living with a partner", "divorced / separated", or "widowed". 
Participants were asked at recruitment how satisfied they were with their lives and with their health, 
with answers categorized as “very satisfied”, “satisfied”, “unsatisfied” and “very unsatisfied”. Men 
were classified as having a history of hypertension or type-2 diabetes at recruitment or at FUP 4 if 
they replied "yes" to the question whether a doctor had ever told them that they had the respective 
disease. Body mass index (BMI) was computed from weight and height, measured by training study 
personnel at recruitment. BMI was categorized into normal (< 25 kg/m²), overweight (25- <30 kg/m²), 
or obese (≥ 30 kg/m²). Waist circumference is an alternative indicator of obesity, which is more 
specific for abdominal obesity. We divided waist circumferences into three categories: low (< 94 cm), 
medium (94-101 cm), and high (≥ 102 cm) 19. At FUP 4 both BMI and waist circumference were self-
reported by the study participants. Physical activity was assessed at baseline using previously 
established (“Cambridge”) Physical Activity Score and categorized into “active”, “moderately active”, 
“moderately inactive”, and “inactive” 20. 
We used computed percentages and means (along with standard deviations [SD]) for descriptive 
analyses. To examine whether selected baseline characteristics were associated with progression of 
LUTS, as assessed in FUP 4, we used logistic regression models to compute odds ratios (OR) and 
corresponding 95% confidence intervals (CI). In all models, we adjusted for age at follow-up 4 and 
time difference between completion of follow-up 4 and follow-up 5. In sensitivity analyses, we used 
different types of adjustment, e.g. we adjusted the associations of BMI and waist circumference for 
smoking status, alcohol consumption, and physical activity (and vice versa); however, as the 
multivariate adjustments did not materially change study findings, we decided to report findings 
based on the model adjusted only for age and time difference between completion of follow-up 4 
and follow-up 5. 
 
Results 
Of 5,495 participants included in our analysis, 1034 (18.8%) progressed from no/mild LUTS to 
moderate/severe LUTS between FUP4 and FUP5 (Table 1). Those who progressed were almost 2 
years older compared with men who did not report moderate/severe LUTS at FUP5, but did not differ 
strongly in mean BMI, in spite of a slightly larger waist circumference. However, men with and 
without progression differed with respect to self-reported diagnosis of BPH at FUP5 (31 vs. 13%) and 
the prevalence of BPH medication use at FUP5 (14 vs. 4%). 
As expected, the odds of having first reports of moderate/severe LUTS symptoms in FUP5 increased 
with increasing age (Table 2). Obese men tended to have a higher odds of LUTS progression, which 
was true for obesity at baseline and obesity at FUP4, although neither OR was statistically significant. 
However, an increase in BMI between baseline and FUP4 of at least 2 BMI units was related to a 
higher odds of LUTS progression (OR = 1.30, 95% CI 1.08-1.57) compared with stable BMI during 
follow-up. On the other hand, there was no association between weight loss and LUTS progression. 
Large waist circumference at baseline was also associated with higher odds of LUTS progression (OR 
= 1.18, 95% CI 0.99-1.40; 102+ cm vs. < 94 cm); the association with waist circumference at FUP4 and 
the increase in waist circumference during follow-up was less strong. 
Smoking habits, alcohol consumption and physical activity at baseline or at follow-up were not 
related with the odds of LUTS progression (Table 2). Compared to men who were very satisfied with 
their life at baseline, those who were satisfied or unsatisfied, but not those who were very 
unsatisfied with their life, were more likely to report LUTS progression. The same was true for 
satisfaction with health at baseline. Adjusting for BMI or lifestyle factors did not attenuate these 
associations (Supplementary Table 1). With respect to chronic disease conditions, neither self-
reported history of diabetes nor hypertension were associated with an increased odds of LUTS 
progression. Marital status was not related to the risk of LUTS progression. Compared with men with 
a primary school degree, men with longer education, e.g. a university degree, had an increased odds 
of LUTS progression. 
 
Discussion 
In this cohort of elderly German men, an increase in BMI, but not in waist circumference, between 
baseline assessment and FUP 4 was associated with LUTS progression. Being less satisfied with health 
and life in general was also associated with LUTS progression. 
Obesity is often associated with elevated insulin concentrations, which have been hypothesized to be 
responsible for an obesity-LUTS association 21. Firstly, a "trophic" effect of high insulin concentrations 
may induce an enlarged prostate, and men with increased prostate size are more likely to develop 
LUTS than men with smaller prostate size 22. Secondly, an increased insulin concentration is also 
associated with an increased sympathetic nerve activity, which increases smooth muscle activity of 
the prostate and may further contribute to LUTS symptoms 21. Several previous studies examined 
obesity as a factor for LUTS progression (see supplementary Table 2). While study designs and 
definitions of LUTS or PBH progression differed, most studies observed associations between obesity 
and LUTS progression irrespective of the outcome's definition. Although in our analysis high BMI at 
baseline or at FUP 4 were not statistically significantly associated with a higher odds of LUTS 
progression, the increase in BMI over a period of 10-14 years (between baseline and FUP 4) was 
related to a 30% higher odds of having moderate/severe LUTS at FUP5. In contrast, we observed no 
strong association between increase in waist circumference over time and LUTS progression. In the 
Prostate Cancer Prevention Trial (PCPT), higher WHR was associated with increased risk of total 
(defined as treatment of LUTS or IPSS > 14 assessed twice) and severe (treatment or IPSS > 20 twice) 
incident BPH 9. In the "Osteoporotic Fractures in Men (MrOS)" study, overweight and obese men had 
a higher risk of developing LUTS 6. In that study, LUTS was defined as IPSS ≥ 8, medication use, or 
surgery. In another analysis of the MrOS study, in which LUTS progression was determined with 
group-based trajectory modeling of the IPSS measures, overweight and obesity were also related to 
LUTS progression 11. In the Health Professionals Follow-up Study (HPFS) 7, higher BMI and greater WC 
were statistically significantly associated with incidence of moderate or worse LUTS (IPSS >=14) or 
progression to severe LUTS (IPSS ≥ 20). In an Australian study, greater abdominal fat mass was 
related to progression of “storage” symptoms of LUTS 10. In the Olmsted County Study 5, in which 
LUTS progression was defined as progression to IPSS ≥ 8 or an increase of at least 4 points, weight 
change was not related to LUTS progression, and no association of BMI or waist circumference with 
LUTS progression (an increase of 8+ points in the IPSS during the 3-year follow-up period) was 
observed in a small Korean study 4.  
Physical activity at baseline showed a suggestive, but statistically non-significantly inverse associated 
with LUTS progression in our cohort. Two studies reported protective effects of physical activity on 
LUTS progression 6,10, but most studies did not see such effects in middle-aged/elderly men 4,8,9,11,12. 
We observed no associations of smoking or alcohol consumption with LUTS progression. Previous 
studies that examined these two lifestyle factors reported mixed results (alcohol no association 4,11 or 
positive association 12; smoking no association 9,11,12 or positive association 4). As in our study, 
previous studies did not report associations between history of chronic diseases such as 
hypertension (no association 11 and type-2 diabetes (no association 4,9,11 and risk of LUTS progression, 
although a number of studies reported positive associations between hypertension and type-2 
diabetes and risk of LUTS or BPH cross-sectionally 23. 
Education was not consistently related with LUTS progression in our analysis, confirming the result of 
one US study 6, whereas a second US study reported that men with lower education had a higher risk 
of LUTS progression 13. 
The only factors that were related to LUTS progression in our study - in addition to weight gain - were 
satisfaction with health and with life in general. This has not been reported before, but numerous 
studies have previously shown that the simple questions of how satisfied somebody is with his life or 
his health is a very good prognostic factor for morbidity and mortality, years and even decades after 
this question has been asked 24. We excluded men with moderate/severe LUTS at FUP 4 and men 
with a diagnosis of LUTS or BPH from the analysis and, thus, pre-existing LUTS is not likely to have 
influenced self-rated health or satisfaction with life. Also, overweight or obese men did not have 
lower satisfaction with health or life than lean men in our analysis (results not shown). It is 
interesting to note that men who were very unsatisfied with health or life were not more likely to 
report LUTS progression. It has been shown that LUTS and BPH affect quality of life 25, but further 
prospective research is warranted to address the opposite question. 
A strength of our study is the rather large sample size of middle-aged and elderly men from the 
general population. Several potential risk factors were assessed at baseline and at FUP4, which 
allowed us for comparing the importance of risk factors depending on lag time. However, BMI and 
waist circumference were assessed differently at baseline (measured at the recruitment center) and 
at FUP4 (self-reported). Similarly, chronic diseases such as hypertension and type-2 diabetes were 
self-reported and have not been verified (besides type-2 diabetes at FUP4) by trained personnel. 
Also, the report of BPH and TURP has usually not been verified by a trained physician unless 
information showed up during verification of cancer. 
In conclusion, we confirm an effect of weight gain on the progression of LUTS in middle-aged and 
elderly men, but other factors of the metabolic syndrome, namely a history of type-2 diabetes and 
hypertension, which have previously been associated with LUTS progression in other cohorts, were 
not associated. The differences in the definition of LUTS progression made it difficult to compare 
results between studies directly and might explain the heterogeneity of findings across different 
studies.  
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Table 1. Selected characteristics of men with and without progression from no/mild 
LUTS to moderate/severe LUTS between follow-up 4 and follow-up 5, EPIC-
Heidelberg 
 
 no progression progression 
   
Participants (N) 4461 1034 
   
 Mean (± SD) Mean (± SD) 
Age at recruitment (years) 50.4 (± 6.8)  52.2 (± 6.8)  
BMI at recruitment (kg/m2) 26.7 (± 3.5) 27.0 (± 3.5)  
BMI at F4 (kg/m2) 27.0 (± 3.7)  27.3 (± 3.8)  
Change in BMI (kg/m2) 0.4 (± 1.9)  0.4 (± 2.0)  
Waist circumference at recruitment (cm) 94.9 (± 9.8) 95.9 (± 9.8)  
Waist circumference at F4 (cm) 99.6 (± 10.6)  100.9 (± 11.0)  
Change in waist circumference (cm) 4.9 (± 7.7) 5.1 (± 7.7)  
   
 N (%) N (%) 
BPH diagnosis between F4 and F5  570 (13) 319 (31) 
BPH surgery between F4 and F5  28 (1) 8 (1) 
Reported use of any BPH medication at F5  192 (4)  148 (14) 
Reported use of α-adrenoreceptor antagonists 
and 5-α reductase inhibitors at F5  77 (2) 70 (7) 
SD, standard deviation; F4, follow-up 4; F5, follow-up 5 
 
Supplementary Table 1. Results of previous studies on LUTS progression risk factors 
Author Country Sample 
size 
Age Assessment Follow-
up 
LUTS progression 
definition 
Exposure OR (95% CI) 
Burke 2006 Olmsted 
County 
2063 40-79 AUA SI 12 years AUA SI* slope, 
>80th percentile 
BMI 25-29.9 vs. <25 kg/m2 0.96 (0.69-1.33) 
     ≥ 30 vs. <25 kg/m2 1.04 (0.73-1.48) 
       WC 95–101 vs < 95 cm 0.99 (0.70-1.38) 
       WC 102–109 vs < 95 cm 0.84 (0.59-1.19) 
       WC >109 vs < 95 cm 1.11 (0.79-1.56) 
Kristal 
2007 
PCPT 5,667 
(placebo 
arm; free 
of BPH 
at 
baseline) 
≥ 55 IPSS 7 years treatment or report 
of 2 IPSS values > 
14 
Light PA vs sedentary 0.92 (0.77-1.09) 
    Moderate PA vs sedentary 0.93 (0.78-1.12) 
     High PA vs sedentary 1.01 (0.79-1.28) 
       current vs non smk 1.01 (0.81-1.27) 
       Diabetes 0.87 (0.66-1.15) 
       weight per 5 kg 1.02 (1.00-1.05) 
       BMI 25-29 vs < 25 kg/m2 1.26 (1.08-1.47) 
       BMI 30-34 vs < 25 kg/m2 1.30 (1.08-1.57) 
       BMI ≥ 35 vs < 25 kg/m2 1.22 (0.92-1.62) 
       WHR 0.95-0.99 vs < 0.95 1.02 (0.88-1.18) 
       WHR 1.00-1.04 vs < 0.95 1.16 (0.98-1.38) 
       WHR ≥ 1.05 vs < 0.95 1.30 (0.95-1.78) 
Parsons 
2011 
MrOS 1695 ≥ 65 AUA SI mean 4.6 
years 
AUA SI ≥ 8; 
documented current 
use of prescription 
medications (α-
adrenergic blockers, 
urinary 
antispasmodics, and 
5α-reductase 
Some college or college 
degree vs high school or less 
0.99 (0.75-1.31) 
      Some grad. school or grad. 
school degree vs high school 
or less 
0.87 (0.65-1.18) 
      BMI 25–29.9 vs < 25 kg/m2 1.29 (1.00-1.68) 
      BMI ≥ 30 kg/m2 vs < 25 kg/m2 1.40 (1.02-1.91) 
      Daily walking 0.80 (0.65-0.98) 
inhibitors for urinary 
symptoms) or self-
report of past use of 
prescription 
medications or non-
cancer prostate 
surgery 
St. Sauver 
2011 
Olmsted 
County 
(OCS) & 
Flint 
Men's 
Health 
Study 
1842 70-79 AUA SI 4 years AUA SI > 7 (OCS 
only) 
Gained < 5% of baseline 
weight vs none 
0.99 (0.75-1.31) 
      Gained ≥ 5% of baseline 
weight vs none 
1.05 (0.80-1.38) 
     4-point Increase in 
AUA SI (OCS only) 
Gained < 5% of baseline 
weight vs none 
0.99 (0.80-1.22) 
       Gained ≥ 5% of baseline 
weight vs none 
1.01 (0.83-1.24) 
Penson 
2011 
US 7318 40-79 IPSS 5 years AUA SI > 7 25–29.9 vs. 18.5-24.9 kg/m2 1.13 (1.00-1.28) 
       30–34.9 vs. 18.5-24.9 kg/m2 1.05 (0.91-1.22) 
       ≥ 35 vs 18.5-24.9 kg/m2 1.34 (1.13-1.58) 
       PA (MET hrs/day) Q1 vs Q4 1.14 (0.99-1.32) 
       PA (MET hrs/day) Q2 vs Q4 0.96 (0.83-1.11) 
       PA (MET hrs/day) Q3 vs Q4 1.04 (0.90-1.20) 
Fowke 
2011 
US 6676 40-79 IPSS 5 years AUA SI > 7 Some college vs college or 
more 
1.26 (1.07-1.49) 
       High school vs college or more 1.28 (1.10-1.49) 
       9-11 yrs vs college or more 1.59 (1.33-1.91) 
       < 9 yrs vs college or more 1.48 (1.17-1.88) 
Maserejian 
2012 
BACH 1610 30-79 at 
baseline 
AUASI 5-year 
fup 
AUA SI ≥ 8  medium vs low PA 1.12 (0.60-2.11) 
      high vs low PA 0.72 (0.35-1.52) 
       former vs never smoking 0.91 (0.51-1.63) 
       current vs never smoking 1.01 (0.55-1.84) 
       0.1-1 vs 0 alcoholic drinks 2.42 (1.24-4.75) 
       >1 vs 0 alcoholic drinks 1.73 (0.87-3.43) 
Mondul 
2014 
HPFS 18055 40-75 AUASI 16 years incidence of 
moderate or worse 
LUTS (IPSS ≥ 15) 
BMI 25-27.5 vs 21-23 kg/m2 1.11 (1.02-1.21) 
      BMI ≥ 35 vs 21-23 kg/m2 1.61 (1.31-1.99) 
       WC 38-40 vs ≤ 33 inches 1.23 (1.05-1.43) 
       WC > 42 vs ≤ 33 inches 1.39 (1.19-1.63) 
       Weight gain 50 pounds vs +/- 
10 since age 21 
1.31 (1.17-1.46) 
Marshall 
2014 
Mr OS 1740 ≥ 65 AUA SI 6 years AUA SI progressing 
trajectory among 
those with AUA SI < 
8 at baseline 
overweight/obese 1.7 (1.0-2.8) 
      no daily walking for exercise 1.4 (0.9-2.2) 
       smoking no sign. 
association 
       alcohol no sign. 
association 
       diabetes no sign. 
association 
       hypertension no sign. 
association 
Choo 2015 Korea 224  ≥ 45 IPSS 3-year 
follow-up 
increase of ≥8 
points 
Body mass index 1.12 (0.88-1.42) 
      Waist  0.92 (0.84-1.01) 
       Diabetes mellitus 1.54 (0.51-4.58) 
       Alcohol 1.01 (0.42-2.41) 
       Smoking 3.08 (1.13-8.36) 
       Leisure-time PA 1.41 (0.63-3.12) 
BMI, body mass index; PA, physical activity; WC, waist circumference; WHR, waist-to-hip ratio 
Table 2. Association between lifestyle and social variables and progression of 
no/mild LUTS to moderate/severe LUTS between follow-up 4 and follow-up 5, EPIC-
Heidelberg 
Variable Unit/category 
Baseline 
information 
OR (95% CI) 
 
Information at F4 
OR (95% CI) 
Age years 1.04 (1.03-1.05)  
BMI < 25 kg/m2 1.00 (ref.) 1.00 (ref.) 
 25 - 29.9 kg/m2 1.07 (0.92-1.25) 1.00 (0.85-1.17) 
 30+ kg/m2 1.16 (0.94-1.42) 1.20 (0.99-1.46) 
BMI change between 
baseline and follow-up 
4 
Decrease > 2 kg/m2  0.90 (0.70-1.16) 
Stable   1.00 (ref.) 
Increase > 2 kg/m2  1.30 (1.08-1.57) 
Waist circumference < 94 cm 1.00 (ref.) 1.00 (ref.) 
 94 - < 102 cm 1.01 (0.86-1.19) 0.96 (0.81-1.15) 
 102+ cm 1.18 (0.99-1.40) 1.13 (0.96-1.33) 
Waist circumference 
change between 
baseline and follow-up 
4 
Decrease > 5 cm  0.92 (0.74-1.13) 
Stable   1.00 (ref.) 
Increase > 5 cm  1.04 (0.89-1.20) 
Smoking habits Never  1.00 (ref.) 1.00 (ref.) 
 Former 1.00 (0.86-1.17) 1.00 (0.86-1.16) 
 Current  0.93 (0.77-1.12) 0.86 (0.69-1.07) 
Physical activity** Inactive  1.00 (ref.)  
 Moderately inactive 0.92 (0.71-1.19)  
 Moderately active 0.91 (0.70-1.18)  
 active 0.85 (0.65-1.10)  
Alcohol consumption No  0.41 (0.12-1.34) 0.44 (0.14-1.46) 
 Former  1.14 (0.77-1.67) 0.88 (0.69-1.13) 
 Current  1.00 (ref.) 1.00 (ref.) 
Satisfaction with life** Very satisfied 1.00 (ref.)  
 Satisfied 1.28 (1.11-1.47)  
 Unsatisfied  1.80 (1.31-2.46)  
 Very unsatisfied 1.43 (0.62-3.34)  
Satisfaction with 
health** 
Very satisfied 1.00 (ref.)  
Satisfied 1.31 (1.13-1.53)  
 Unsatisfied  1.51 (1.20-1.92)  
 Very unsatisfied 0.89 (0.45-1.76)  
Diabetes Yes  1.14 (0.79-1.65) 0.98 (0.77-1.25) 
Hypertension Yes  1.07 (0.92-1.24) 0.98 (0.84-1.13) 
Marital status Single  1.00 (ref.) 1.00 (ref.) 
 Married 1.03 (0.79-1.35) 1.10 (0.82-1.47) 
 Divorced 0.94 (0.65-1.36) 1.12 (0.77-1.63) 
 Widowed  0.56 (0.24-1.29) 1.15 (0.71-1.86) 
Education** No formal degree 1.89 (0.57-6.26)  
 Primary school 1.00 (ref.)  
 Techn./prof. school 0.98 (0.81-1.18)  
 Secondary school 1.17 (0.86-1.59)  
 Longer education 1.25 (1.06-1.48)  
* adjusted for age at follow-up 4 and time between follow-ups 4 and 5 (both 
continuous); changes in BMI and waist circumference are adjusted for BMI at 
baseline and waist circumference at baseline, respectively 
** not assessed at follow-up 4 
